Literature DB >> 9797383

Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception.

W E Whitehead1, O S Palsson.   

Abstract

BACKGROUND & AIMS: Rectal pain sensitivity has been called a biological marker for irritable bowel syndrome, but this conclusion may be premature. This article is a critical review of the evidence for psychological influences on perception.
METHODS: The world literature accessible through Index Medicus from 1973 to 1997 was systematically reviewed.
RESULTS: Evidence favoring a biological basis for pain sensitivity is that two thirds of patients report pain at abnormally low thresholds of rectal distention despite normal somatic pain thresholds. Pain thresholds are not correlated with anxiety or depression. Evidence favoring psychological influences on perception is that patients with the irritable bowel syndrome rate even sham distentions as more painful, and when perception tests that minimize psychological influences are used, they have normal sensory thresholds. Also, stress alters sensory thresholds. Sensitization by repeated distention has been cited as evidence of a biological basis for hyperalgesia, but it is not unique to patients with irritable bowel. Brain imaging shows that different regions are activated by painful distention in patients with irritable bowel syndrome, but this is consistent with psychological influences on perception.
CONCLUSIONS: Psychological factors influence pain thresholds in patients with the irritable bowel syndrome. Two cognitive traits, selective attention to gastrointestinal sensations and disease attribution, may account for increased pain sensitivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797383     DOI: 10.1016/s0016-5085(98)70099-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  73 in total

1.  Some of the challenges in drug development for irritable bowel syndrome.

Authors:  E A Mayer
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Brain-gut axis as an example of the bio-psycho-social model.

Authors:  I Wilhelmsen
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 3.  Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.

Authors:  M Camilleri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 4.  Brain imaging and functional gastrointestinal disorders: has it helped our understanding?

Authors:  A R Hobson; Q Aziz
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome.

Authors:  Elham Barkhordari; Nima Rezaei; Mahdi Mahmoudi; Pegah Larki; Hamid Reza Ahmadi-Ashtiani; Bita Ansaripour; Maryam Alighardashi; Mohammad Bashashati; Ali Akbar Amirzargar; Naser Ebrahimi-Daryani
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

6.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

7.  Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists.

Authors:  D A Drossman
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 8.  How do SSRIs help patients with irritable bowel syndrome?

Authors:  F Creed
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

9.  Visceral sensitivity in irritable bowel syndrome and healthy volunteers: reproducibility of the rectal barostat.

Authors:  Signe Spetalen; Morten B Jacobsen; Morten H Vatn; Svein Blomhoff; Leiv Sandvik
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

10.  Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome.

Authors:  Olafur S Palsson; Olivier Morteau; Eugene M Bozymski; John T Woosley; R Balfour Sartor; Michael J Davies; David A Johnson; Marsha J Turner; William E Whitehead
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.